Mayo Clinic: Colorectal Neoplasms trials

The registry lists 16 Colorectal Neoplasms studies with Mayo Clinic as lead sponsor. 8 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 4Phase 2 4No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot TrialRecruitingNCT07618273Not applicable
• HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein EmbolizationNot yet recruitingNCT07612007Phase 2
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
• Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformRecruitingNCT06349642
• Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramRecruitingNCT06265285Phase 2
• Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix CommunitiesRecruitingNCT05447923Not applicable
• Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome PatientsRecruitingNCT05410977
• Intravital Microscopy in Human Solid TumorsRecruitingNCT03823144Not applicable
• Evaluating the Safety and Effectiveness of the Flex Robotic System for the Surgical Removal of Colorectal LesionsCompletedNCT05674123Not applicable
• A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal CancerCompletedNCT05130060Phase 1
• Promoting Equity for Cancer Screening and Follow-upWithdrawnNCT04831827Not applicable
• Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerCompletedNCT04067960Early Phase 1
• TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsTerminatedNCT02650635Phase 1
• Linaclotide Acetate in Preventing Colorectal Cancer in Healthy VolunteersCompletedNCT01950403Phase 1
• Unprepped CT ColonographyCompletedNCT00586053
• Stage IV Colorectal CA ALIMTACompletedNCT00166465Phase 1/2